Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wallis

Showing results (291-300 of 332) with videos related to

Pageof 34
Sort By:
Infection and Immunity|April 9, 2001
Flagellar phase variation of Salmonella enterica serovar Typhimurium contributes to virulence in the murine typhoid infection model but does not influence Salmonella-induced enteropathogenesisJ S Ikeda, C K Schmitt, S C Darnell, et al.
American Journal of Respiratory and Critical Care Medicine|April 14, 2000
Predicting the outcome of therapy for pulmonary tuberculosisR S Wallis, M D Perkins, M Phillips, et al.
The Journal of Infectious Diseases|November 7, 1998
Induction of the antigen 85 complex of Mycobacterium tuberculosis in sputum: a determinant of outcome in pulmonary tuberculosis treatmentR S Wallis, M Perkins, M Phillips, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2019
A Common NLRC4 Gene Variant Associates With Inflammation and Pulmonary Function in Human Immunodeficiency Virus and TuberculosisShruthi Ravimohan, Pholo Maenetje, Sara C Auld, et al.
The Journal of Infectious Diseases|April 8, 2000
Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected ugandan adults with newly diagnosed pulmonary tuberculosis. The Uganda-Case Western Reserve University Research CollaborationJ L Johnson, R M Kamya, A Okwera, et al.
IJTLD Open|May 14, 2025
Neuromyelitis optica causing vision loss during TB treatment with sutezolid: evidence of aberrant immunity following infectionN A Glover, L Paramo, S Giangregorio, et al.
The Journal of Infectious Diseases|June 30, 2023
Circulating Biomarkers, Fraction of Exhaled Nitric Oxide, and Lung Function in Patients With Human Immunodeficiency Virus and TuberculosisPholo Maenetje, Yeonsoo Baik, Diana B Schramm, et al.
Developmental Cell|November 24, 2021
The ESCRT machinery counteracts Nesprin-2G-mediated mechanical forces during nuclear envelope repairSamuel S Wallis, Leandro N Ventimiglia, Evita Otigbah, et al.
The Journal of Infection|January 5, 2025
N-acetylcysteine modulates markers of oxidation, inflammation and infection in tuberculosisDaniel Adon Mapamba, Issa Sabi, Julieth Lalashowi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2019
Lung Injury on Antiretroviral Therapy in Adults With Human Immunodeficiency Virus/TuberculosisShruthi Ravimohan, Sara C Auld, Pholo Maenetje, et al.
Pageof 34

Showing results (291-300 of 332) with videos related to

Sort By:
Pageof 34
Infection and Immunity|April 9, 2001
Flagellar phase variation of Salmonella enterica serovar Typhimurium contributes to virulence in the murine typhoid infection model but does not influence Salmonella-induced enteropathogenesisJ S Ikeda, C K Schmitt, S C Darnell, et al.
American Journal of Respiratory and Critical Care Medicine|April 14, 2000
Predicting the outcome of therapy for pulmonary tuberculosisR S Wallis, M D Perkins, M Phillips, et al.
The Journal of Infectious Diseases|November 7, 1998
Induction of the antigen 85 complex of Mycobacterium tuberculosis in sputum: a determinant of outcome in pulmonary tuberculosis treatmentR S Wallis, M Perkins, M Phillips, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2019
A Common NLRC4 Gene Variant Associates With Inflammation and Pulmonary Function in Human Immunodeficiency Virus and TuberculosisShruthi Ravimohan, Pholo Maenetje, Sara C Auld, et al.
The Journal of Infectious Diseases|April 8, 2000
Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected ugandan adults with newly diagnosed pulmonary tuberculosis. The Uganda-Case Western Reserve University Research CollaborationJ L Johnson, R M Kamya, A Okwera, et al.
IJTLD Open|May 14, 2025
Neuromyelitis optica causing vision loss during TB treatment with sutezolid: evidence of aberrant immunity following infectionN A Glover, L Paramo, S Giangregorio, et al.
The Journal of Infectious Diseases|June 30, 2023
Circulating Biomarkers, Fraction of Exhaled Nitric Oxide, and Lung Function in Patients With Human Immunodeficiency Virus and TuberculosisPholo Maenetje, Yeonsoo Baik, Diana B Schramm, et al.
Developmental Cell|November 24, 2021
The ESCRT machinery counteracts Nesprin-2G-mediated mechanical forces during nuclear envelope repairSamuel S Wallis, Leandro N Ventimiglia, Evita Otigbah, et al.
The Journal of Infection|January 5, 2025
N-acetylcysteine modulates markers of oxidation, inflammation and infection in tuberculosisDaniel Adon Mapamba, Issa Sabi, Julieth Lalashowi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2019
Lung Injury on Antiretroviral Therapy in Adults With Human Immunodeficiency Virus/TuberculosisShruthi Ravimohan, Sara C Auld, Pholo Maenetje, et al.
Pageof 34